Markwayne Mullin’s Kratom Investment Draws New Scrutiny on Tucker Carlson Podcast
Markwayne Mullin's kratom investment drew fire from Tucker Carlson, who tied the DHS chief to a drug "killing kids."

On the latest episode of The Tucker Carlson Show, Tucker Carlson criticized Homeland Security Secretary Markwayne Mullin for investing in a kratom company and lobbying for policies that would benefit it.
“It’s also true that Markwayne Mullin is a part owner of a kratom company,” Carlson said.
“Without getting too far afield, what’s kratom? Well, kratom is a as yet not banned by the feds substance that’s sold in many convenience stores that acts on the brain much like opiates do. It’s addictive. It’s fatal in high doses. And it’s in a lot of places completely legal.”
Carlson said Mullin “personally invested in a drug that is addicting kids and killing kids in the country … So, you have to ask yourself, like, what kind of person would invest in something that killed American kids, and not just invested in it, but has, according to news reports, personally lobbied throughout the administration to keep it legal so he can keep getting paid.”
Get stories like this every Friday
The week's drug policy news in one email, every claim sourced. Join tens of thousands of readers.
“This is a callous, cruel person who just doesn’t care about other human beings,” Carlson said.
Carlson was alluding to an investigation published in June by the New York Times, which found that Mullin “played a key role in a sprawling influence campaign spearheaded by the kratom industry that courted Health Secretary Robert F. Kennedy Jr. and Vice President JD Vance, among others in the Trump administration.” It noted that Mullin had an investment worth as much as $1 million in Botanic Tonics, a kratom company known for selling products like “Feel Free.”
The New York Times also spoke to sources who said Mullin “urged officials in the health department to remove language from the F.D.A. website warning of kratom’s harms.” A Cabinet secretary with a personal stake in a kratom company pushed regulators to downplay and stop warning Americans about its harms.
Kratom has not been approved by the Food and Drug Administration for the treatment of any disease or condition. The Drug Enforcement Administration labeled it one of its “drugs of concern.” Most recently, kratom was involved in the deaths of two Ole Miss students.
As of June 2026, Mullin had not filed paperwork declaring that he had divested his investment in Botanic Tonics, the New York Times reported.
Mullin’s investment is concerning because federal policy should be guided by evidence, not by personal profits.
Get The Drug Report every Friday
One free email every Friday: the week's drug policy news, sourced and explained. Read by tens of thousands of people who write, enforce and cover the policy. Unsubscribe anytime.
